Boston Partners

SEC CIK: 0001386060
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overview All 13F holders of NBIX Full Q2 2026 holdings

Shares (Q2 2026): 59,268
Value: $9.99M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of NBIX by Boston Partners, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	59,268	$9.99M	<0.1%	+12,980+28.0%	Added	Holders
Q1 2026	46,288	$6.10M	<0.1%	−8,184−15.0%	Reduced	Holders
Q4 2025	54,472	$7.73M	<0.1%	+54,472	New	Holders